ArticleValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research2025
Mapping EQ-5D-5L Utilities in Dementia: Integrating Self and Proxy Reports.
Article in Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Proxy reports on the EQ-5D-5L in residential aged care facilities: a validation study.Health and quality of life outcomes · 2026Trial
- The economics of decision-making in dementia care and related life-limiting illness: a narrative review.Health economics review · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesEQ-5D is widely used in dementia research, but cognitive impairments often necessitate proxy assessments, resulting in differences between self- and proxy-reported data. Some EQ-5D dimensions are better reported by people with dementia (PwD), particularly in the mild to moderate stages, whereas others are more accurately captured by proxies. This study evaluates whether a combined utility value, integrating both PwD and proxy reports, can be predicted when data from only 1 respondent type are available.
methodsData from 2 dementia studies, ACTIFCARE and EPIC, were used to develop mapping models aimed at predicting combined utility values. These models integrate dimension-specific EQ-5D-5L responses from both respondent types to enhance health-related quality-of-life (HRQoL) assessments. Response mapping with ordered probit models was used to predict EQ-5D-5L responses when only 1 respondent type's data were available. Model performance was evaluated by comparing observed and predicted data across dementia severity stages.
resultsCombined utility values provided a more accurate reflection of HRQoL, showing greater sensitivity to health status changes. Proxy data proved to be more effective in predicting PwD responses for certain EQ-5D-5L dimensions, suggesting that proxy data collection may be particularly useful in specific situations. The mapping models performed well for mild-to-moderate dementia but were less accurate in severe dementia because of limited data.
conclusionsCombined utility values improve HRQoL assessments, particularly in detecting subtle health changes in mild-to-moderate dementia. These models support their use in economic evaluations of dementia interventions, although challenges remain in severe dementia because of data limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.